To ensure that evidence-based diabetes care is personalised, international diabetes guidelines emphasise the importance of SDM. 10–13 SDM is crucial for the practice of evidence-based medicine. To form sensible plans of care that respond well to and advance the situation of the individual patient, that is, to make care fit, patients and clinicians must collaborate to determine what to do, work often referred to as shared decision-making (SDM). novel pharmacological agents (such as GLP-1 (glucose-like peptide 1) receptor agonists 1 2 and sodium-glucose cotransporter-2 (SGLT2) inhibitors 1 2) and technological innovations (such as flash glucose monitoring, 3–6 smart insulin pens 6 7 and pumps 6 and the artificial pancreas 8 9) are rapidly changing the field. This is especially pertinent in diabetes care, where the development of e.g. Biomedical and technological advances in healthcare have resulted in an increased array of treatment options available to improve healthcare outcomes.
0 Comments
Leave a Reply. |